Communicable diseases were traditionally the major cause of public health concern in Asian countries, most of which were less developed. With industrialization and associated lifestyle changes during the past few decades, however, noncommunicable diseases similar to those that affect Western societies have emerged in Asian countries. The purpose of the review was to examine recent evidence about the burden and factors associated with hypertension and chronic kidney disease (CKD) in Asian countries.
Introduction
Communicable diseases were in the past the main causes of death worldwide and life expectancy was often limited by uncontrolled epidemics. Improvement of sanitary conditions and living conditions as well as medical advances in terms of vaccination and antibiotics, however, have successfully reduced infant mortality and deaths from infectious diseases. On the other hand, adopting the lifestyle of industrialized nations -such as decreased physical activity and increased intake of dietary fats -have resulted in the emergence of noncommunicable diseases as major problems in developing countries. Cardiovascular and kidney diseases, cancer, diabetes, chronic pulmonary and mental diseases pose an immense burden for health systems in both developed as well as developing countries, many of which are in Asia [1] . In 1990, for example, the leading causes of disease burden were pneumonia, diarrheal diseases, and perinatal conditions. It is predicted that by 2020 noncommunicable disease will account for 80% of the global burden of disease, causing seven out of every 10 deaths in developing countries [2, 3] .
Hypertension
Hypertension is one of the most important modifiable risk factors for cardiovascular disease (CVD) and chronic kidney disease (CKD) [4, 5] . The prevalence of hypertension in countries in the Asian region is rising [6] , but rates of awareness and adequate control of blood pressure remain appallingly low [7] . National-level efforts to stem the rising tide of hypertension are lacking in most Asian countries.
Despite the publications of several hypertension treatment guidelines, primary care practitioners continue to grossly under-diagnose and under-treat hypertension [8] . It appears that Asians are especially susceptible to insulin resistance, which may in part be due to past history of under-nutrition or low birth weight [9] . The presence of insulin resistance compounds the deleterious impact of high blood pressure in a synergistic manner in this vulnerable population, which is now facing an explosion of diabetes in epidemic proportions [2, 10] . Ominously, other risk factors predisposing to CVD and CKD such as tobacco use, dietary fat intake, and sedentary lifestyles are also becoming widespread [11] .
During the past two decades, China, the most populous nation in the world, has witnessed a doubling of the number of deaths attributed to chronic diseases, in particular hypertension. In the recently conducted nationally representative China National Hypertension Survey Epidemiology Follow-up Study [12 ] on 169 871 adult men and women, the single most important factor identified in terms of magnitude of adjusted relative risk as well as attributable risk of death was hypertension.
The prevalence of hypertension continues to rise in China. In 1998, 24% of population aged 35-59 years suffered from this condition -a 2.3% increase compared with 1992-1994. Among hypertensive Chinese subjects, 42.6% were aware of their hypertension, 31.1% were treated, and merely 6% were controlled [6] .
Data from Indo-Asian countries suggest an even higher burden of hypertension. Results from the National Health Survey of Pakistan 1990-1994 indicate that about onethird of the general population in Pakistan aged 40 years or over suffered from high blood pressure. Moreover, 70% of hypertensive patients were unaware of their condition, and blood pressure control rates (3%) were dismal. In fact, the vast majority of adults have never had their blood pressure checked [7, 13] . This is a reflection of the existing healthcare systems in developing countries that are sensitized mainly towards providing acute, symptomatic treatment for infectious diseases, and are not accustomed to providing preventive care for chronic diseases.
Knowledge regarding cardiovascular health issues, including hypertension, is severely lacking in some Asian countries. These gaps in knowledge coupled with high illiteracy rates translate into inadequate preventive healthcare practices [14] . Lack of hypertension screening and control programs in these regions means that mortality from this condition is only expected to escalate further [6, 7] .
Risk factors for hypertension
Most of the rise in the prevalence of hypertension in countries such as China, Thailand, India, Pakistan, and other Asian countries can be explained by changes in distributions of body-mass index (BMI). Saturated fat intake, insulin resistance, and blood cholesterol levels have also increased concomitantly [15, 16] .
This issue may be more complex as the downstream adverse consequences at any given severity of risk factor may be worse in Asian populations. For example, compared with white children in the US, children in Pakistan had higher blood pressure at any given BMI level ( Fig. 1 ) [17] . Evidence suggests that associations between BMI, percentage of body fat, and health risks may differ in Asian and Western populations [18] . It has been shown that in order to identify subjects at high risk of CVD, lower values for BMI and waist circumference should be used for Asian patients than the conventional cutoff values for Western subjects [19] . One proposed explanation for these observed differences in magnitude of risk among Asians is the effect of poverty and resultant malnutrition during intrauterine and early childhood years. There may, however, also be other unexplained factors at work [20] .
Chronic kidney disease: low glomerular filtration rate
In parallel with the sky-rocketing prevalence of uncontrolled hypertension and diabetes in Asia, the burden of CKD as defined by a decreased level of estimated glomerular filtration rate (GFR) or albuminuria is also expected to rapidly escalate in this region.
Adverse outcomes of CKD include loss of kidney function, sometimes leading to kidney failure, and CVD. Unfortunately, CKD is under-diagnosed and under-treated [21, 22] . This problem is compounded in developing countries that have poorly developed and underresourced healthcare system infrastructure. To give a concrete example, in Indo-Asian countries, the annual cost of dialysis is about US$4000. Kidney transplantation cost about US$5000, and post-transplant medications cost $2000 annually. Compared with this, the average yearly per-capita income is $279; 36% of the population earns less than $105 per annum, and only 2.2% earn more than $1000 [23] . These countries therefore simply cannot afford to treat kidney failure. Mortality due to untreated CKD, although not well documented and quantified, is likely to be very high.
A recent cohort study [24] [26] . A wide discrepancy in estimated disease prevalence is therefore obtained depending on whether the Cockcroft-Gault or the MDRD equation is used to estimate renal function in these participants. Agreement among GFR estimation equations and the measured GFR (or creatinine clearance) has been reported to be suboptimal in Asian populations [27 ,28 ] . A lower creatinine excretion in Indo-Asian men and women (17.5 and 14.1 mg/kg per day, respectively) has been reported compared with the expected values (19.0 and 16.3 mg/ kg per day; P < 0.002 and P < 0.001, respectively) in their Caucasian counterparts [27 ] . This may be explained by a lower body muscle mass and lower meat intake in Indo-Asians compared with white Caucasians. Improvements in the existing GFR estimation equations taking into account these differences are therefore needed for Asian populations.
Finally to complicate matters more, data from 610 young India potential kidney donors (with presumed normal kidney function) showed that the mean GFR values of Indians measuring using 99 mTc-diethylenetriamine pentaacetic acid plasma clearance was 81.4 AE 19.4 ml/min per 1.73 m 2 -significantly lower than what has been reported for their Western counterparts (109-125 ml/min per 1.73 m 2 body surface area) [29 ] . This implies that even the GFR thresholds used to define CKD derived from Western subjects may need to be modified for Asian populations. Alternatively, kidney disease may be far more prevalent in this population than is currently appreciated.
More research is therefore needed to define population GFR norms, and to develop accurate renal function Hypertension and kidney disease in Asia Jafar 293 estimation equations applicable to Asian populations from serum creatinine and other markers.
The general paucity of clinical trials conducted in indigenous Asian populations as well as lack of Asian subjects in those conducted in the West raise similar concerns about the applying these treatment targets and interventions strategies to Asian populations.
Chronic kidney disease: albuminuria
The other prominent aspect of CKD -albuminuriaalso seems to be highly prevalent across Asia. This is not unexpected given the increasing prevalence of diabetes in this region. In the Microalbuminuria Prevalence Study [30] , the prevalence of macroalbuminuria was 18.8% and microalbuminuria was 39.8% among 6800 hypertensive diabetic adult patients from 10 Asian countries.
Although national-level general population data based on sound sampling strategies are needed for accurate assessment of burden of albuminuria and various stages of CKD in Asian countries, available evidence suggests a very high prevalence of CKD, and its risk factors in the Asian Pacific region.
Risk factors for CKD
Studies suggest that the main risk factors associated with CKD in the Asian populations include elevated blood pressure, elevated blood glucose and cholesterol levels, smoking, and high BMI [24,31,32,33 ,34] . Most of these are similar to those identified in Western populations [35, 36] . The prevalence of CKD also appears to increase with increase in age in Asian countries [31] . To a significant extent this is due to the acquisition of the aforementioned risk factors, which are also associated with aging and often confound the association between age and CKD [24] .
An as yet unresolved issue that relates to the Asian population is that of possible greater susceptibility of CKD because of a higher background prevalence of low birth weight or malnutrition [37] [38] [39] . A number of regional and global efforts have led to an overall improvement in the latter trends [40, 41] , and these efforts must continue. On the other hand, conventional risk factors for CKD are on the rise in Asia so programs that focus on prevention of CKD targeting conventional modifiable risk factors, including high blood pressure, diabetes, cholesterol, tobacco cessation, reduction in intake of saturated fats, and obesity, are urgently needed in Asian countries.
Future direction for research in Asians
More research is needed in the Asian population, mainly focusing on cost-effective strategies for early detection and prevention of hypertension, and CKD. This would include understanding the feasibility and efficacy of screening programs. Efforts are needed to study normal levels of GFR, and to develop and validate GFR estimation equations from serum creatinine and other markers that are applicable in this population. Prospective, well controlled studies are needed in the Asian populations to define appropriate target levels of risk factors, including the optimal level of BMI, waist circumference, cholesterol levels, blood pressure levels, and urine albumin excretion for prevention of morbidity and mortality from hypertension and CKD.
Conclusion
Hypertension is one the leading causes of mortality in Asia. Despite rising prevalence it remains under-diagnosed and under-treated. CKD is becoming increasingly common mainly due to an increase in conventional risk factors including high blood pressure, diabetes, and obesity. Early detection of CKD in Asians is challenging as equations to estimate GFR have not been validated in this population.
It is clear that well designed, cost-effective programs are needed to control hypertension and CKD, targeting their risk factors. These should include multiple strategies for primary and secondary prevention. Efforts need to be made to integrate these programs into the existing healthcare infrastructure for ensuring long-term sustainability.
Public education about adoption of healthy lifestyles must be one of the essential aims of such programs. It must, however, be coupled with appropriate public policy interventions that ensure affordability and access of such choices (e.g. antitobacco legislation and ban on sale of saturated oil), especially in countries where literacy rates are poor [11] . Cheap and reliable screening tests need to be used for population screening. Industry support is desired for subsidization of cost of effective medications, which are necessary for many high-risk individuals [42] .
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